Management of Autoimmune Hepatitis with Fulminant Liver Failure
Diagnostic Approach
- Fulminant autoimmune hepatitis (AIH) is defined as hepatic encephalopathy within 26 weeks of disease discovery with or without cirrhosis, occurring in approximately 6% of AIH patients 1, 4
- The American Association for the Study of Liver Diseases recommends that ANA is absent or weakly positive in 29-39% of cases, and serum IgG levels are normal in 25-39% of patients 1, 2, 4
- Diagnostic scores by international scoring systems are typically lower than in classical chronic presentations 1
- Liver biopsy should be performed if the patient's condition allows, as it provides critical diagnostic information, with characteristic findings including centrilobular hemorrhagic necrosis with lymphoplasmatic infiltration, lymphoid aggregates, and plasma cell infiltration 1, 4, 5, 6
- Imaging findings that support diagnosis include heterogeneous hypoattenuated areas on non-contrast CT scan, present in 65% of patients with fulminant AIH 3
Treatment Approach
- Immediate immunosuppressive therapy should be initiated once other causes of acute liver failure are excluded, even with atypical serological findings, with high-dose prednisolone as the preferred drug 1, 5, 7
- Standard induction treatment should be offered to patients with moderate or severe inflammation, according to the British Society of Gastroenterology 5, 7
Clinical Pearls and Pitfalls
- The European Association for the Study of the Liver recommends that treatment should not be delayed while waiting for "classical" serological findings to appear, as the absence of typical markers does not exclude the diagnosis in fulminant presentations 1, 4
- A short (≤2 weeks) prednisolone trial is appropriate when the diagnosis is uncertain but AIH is suspected, as recommended by the American Association for the Study of Liver Diseases 1, 2
- Liver biopsy is crucial but should not delay treatment if the patient's condition is deteriorating rapidly, according to the American Association for the Study of Liver Diseases 1, 6